Xtx Topco LTD An2 Therapeutics, Inc. Transaction History
Xtx Topco LTD
- $2.23 Billion
- Q2 2025
A detailed history of Xtx Topco LTD transactions in An2 Therapeutics, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 26,044 shares of ANTX stock, worth $34,117. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,044Holding current value
$34,117% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding ANTX
# of Institutions
38Shares Held
7.58MCall Options Held
0Put Options Held
0-
Almitas Capital LLC Santa Monica, CA1.43MShares$1.87 Million0.71% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.04MShares$1.36 Million0.0% of portfolio
-
Peapod Lane Capital LLC Bedford Hills, NY583KShares$763,4280.62% of portfolio
-
Stonepine Capital Management, LLC Bend, OR544KShares$713,2870.57% of portfolio
-
Landscape Capital Management, L.L.C.495KShares$648,9680.05% of portfolio
About AN2 Therapeutics, Inc.
- Ticker ANTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 19,402,700
- Market Cap $25.4M
- Description
- AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menl...